MAM misses out as financials lead blue-chip surge
Thursday 17 July 1997
Footsie climbed to yet another peak but MAMs fell 16.5p to 1,272.5p. The shares have found the going uncomfortable since peaking at 1,463.5p in May. The market is uneasy over the group's investment performance. The most persistent story is it suffered a poor second quarter and, in certain areas, is, in effect, bottom of the class.
It appears its mixed equity and property fund had a particularly unimpressive time.
PDFM, the fund management arm of Swiss owned UBS, is another said to have underperformed in the second quarter. It has for long been banking on an equity collapse, putting a surprising large slice of its funds into cash.
There is no doubt that many fund managers have been caught on the hop by the strength of equities. The chorus of caution in the Merrill Lynch survey could be an illustration of their misjudgement.
MAMs, with around pounds 70bn under management, has been the deciding influence in many big takeover battles. It ensured Granada won the fierce pounds 3.9bn battle for control of the Forte catering and hotel empire.
Whether MAMs and its investment supremo, the remarkable Carol Galley, have misjudged equities remains to be seen. The share performance, even with the help of occasional takeover interest, is suggesting MAMs may have underperformed.
Footsie managed another unabashed, heady gallop. Once again overseas investors were out in force. In heavy trading - Seaq volume topped 1 billion shares - the blue-chip index soared 64.9 points to 4,964.2. At one time it seemed intent on surging through the 5,000 barrier. In mid afternoon it was up 92.5 at 4,991.8.
Then New York introduced a little caution into the proceedings. In the event it shrugged off early hesitancy and during London hours smashed through 8,000 points.
Compared with New York and European markets London looks cheap. Overseas investors are unworried by the increasingly inflated valuations which, anyway, are still below those in most other markets.
Even so, the feeling shares are rising too quickly, too steeply prevails in many quarters. There is a tendency to draw comparisons with the 1987 crash; the anniversary of the great equities blood bath is drawing uncomfortably near.
Although the FTSE 250 index jumped 36 points blue chips remained the attraction, underlining overseas buying.
Some foreigners feel quite adventurous trading in London; they are not, however, going to wander outside the comfort and protection of leading equities.
Financials again had a good run with HSBC powering ahead 65p (after 116p) to 2,151p. National Westminster Bank, on the rumoured shake-up at its securities arm, recovered 21p to 874p.
The market still feels a big financial bid is being hatched. HSBC has at one time or another been linked with almost every financial in sight. Abbey National, currently bidding for Cater Allen, is another seen as strongly acquisitive.
Drugs, a long-time favourite of US fund managers, enjoyed support. They continue to direct their attention towards the bigger players with Zeneca up 67p to 2,265p; only six months ago speculators were piling into the shares in the hope of a bid materialising at around 2,200p.
ScottishPower had an eventful session, closing 20p higher at 467p. Some chunky trades went through with some suggesting technical influences.
BT continued to feel the impact of the MCI fiasco, falling 7p to 445.5p. The latest twist in the drink merger cocktail lifted Grand Metropolitan 15.5p to 621.5p and Guinness 14.5p to 620.5p.
Among supporting shares British Biotech continued to rally, up 15.5p to 183p but Medeva fell 34.5p to 222p with worries about Ionamin, the recent subject of a "Dear Doctor" letter from the US Food and Drug Administration.
Iceland, the frozen food chain, rose 3p to 90.5p as Credit Lyonnais Laing hung a buy sign over the shares and Northern Foods jumped 11.5p to 224.5p on SBC Warburg support.
TI, the engineer, enjoyed a NatWest Securities recommendation, putting on 18.5p to 511p.
A trading warning left Plasmon, an electronic equipment group, wallowing 86.5p lower at 92.5p and a profits fall programmed Microgen, a computer concern, 31p down to 118.5p.
- 1 Israel-Gaza conflict: 'When Genocide is Permissible' article removed from The Times of Israel website
- 2 Pope Francis issues top 10 tips for happiness
- 3 Disney heiress Abigail disowns her share of family profits in West Bank company
- 4 The secret report that helps Israel hide facts
- 5 Israel's propaganda machine is finally starting to misfire
Lost portraits of the Somme: 100 images of Tommies posing before they went over the top. Now can you help to identify them?
Israel-Gaza conflict: 'When Genocide is Permissible' article removed from The Times of Israel website
Mystery of the Siberian holes at the end of the world 'solved': Scientists offer explanation
Pope Francis issues top 10 tips for happiness
Sabina Altynbekova, the girl branded 'too good looking' for volleyball, says social media obsession with her is a 'bit much'
Land for gas: Merkel and Putin discussed secret deal could end Ukraine crisis
Woman and two children killed by mob in riots over 'blasphemous' Facebook post in Pakistan
Richard Dawkins tweets: 'Date rape is bad, stranger rape is worse'
Putin is 'thuggish, dishonest and reckless', says British ambassador to US
Boozy, ignorant, intolerant, but very polite – Britain as others see us
A new Russian revolution: The cracks are starting to appear in Putin’s Kremlin power bloc
- < Previous
- Next >
iJobs Money & Business
£300 - £350 per day: Orgtel: Financial Analyst, Forecasting, Halifax, Banking,...
£500 per day: Orgtel: Business Architect - Banking - Bristol - £500 per day A...
£200 - £500 per day + competitive: Orgtel: I am currently working on a large p...
£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...